TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 44 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $319,924 | -20.4% | 484,000 | -4.0% | 0.03% | -28.9% |
| Q1 2023 | $401,990 | -68.2% | 504,000 | -10.0% | 0.04% | -60.8% |
| Q4 2022 | $1,265,600 | +227.9% | 560,000 | +180.0% | 0.10% | +234.5% |
| Q3 2022 | $386,000 | -37.1% | 200,000 | +21.2% | 0.03% | -31.0% |
| Q2 2022 | $614,000 | – | 165,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 1,147,040 | $13,363,000 | 6.07% |
| Sands Capital Ventures, LLC | 724,873 | $8,445,000 | 1.25% |
| Quantum Private Wealth, LLC | 145,718 | $1,697,000 | 0.64% |
| Nantahala Capital Management | 1,456,147 | $16,964,000 | 0.60% |
| Artal Group S.A. | 1,040,882 | $12,126,000 | 0.33% |
| Alphabet Inc. | 640,882 | $7,466,000 | 0.18% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $5,825,000 | 0.17% |
| TimesSquare Capital Management, LLC | 659,100 | $7,679,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 40,885 | $476,000 | 0.06% |
| Virtus ETF Advisers LLC | 11,519 | $134,000 | 0.05% |